Status:

UNKNOWN

Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer

Lead Sponsor:

Chinese Academy of Medical Sciences

Collaborating Sponsors:

Zhejiang Cancer Hospital

Cancer Hospital of Guizhou Province

Conditions:

Rectal Neoplasms

Eligibility:

All Genders

18-75 years

Brief Summary

The purpose of this study is: * To compare the long-term of survival and local/regional control between the two postoperative concurrent chemoradiotherapy regimens: capecitabine vs. oxaliplatin and c...

Detailed Description

Adjuvant 5-FU based concurrent chemoradiotherapy and chemotherapy is the standard care for locally advanced stage II-III rectal cancer, based on several randomized Phase III clinical trials. With this...

Eligibility Criteria

Inclusion

  • 18-75 years old,male or female
  • R0 surgery
  • Pathologically approved as stage II or stage III
  • Enrolled within 6 months from the date of surgery
  • Upper border of tumor before surgery was under L5
  • KPS\>70% or ECOG 0-2
  • No prior radiotherapy in the past 6 months
  • Received chemotherapy no more than 4 cycles after surgery
  • HGB\>100 g/L, WBC≥3.5x109 /L, PLT≥100x109 /L; CR\<1.5 x Upper normality,TB\<2.5 X Upper normality,AST or ALT\<2.5 x Upper normality,AKP\<2.5 X Upper normality
  • Signed consent

Exclusion

  • Other malignancies simultaneously except in situ cervix or nonmelanoma skin cancer
  • Pregnancy or in lactation
  • HGB\<100 g/L, WBC\<3.5x109 /L, PLT\<100x109 /L; CR≥1.5 x Upper normality,TB≥2.5 X Upper normality,AST or ALT≥2.5 x Upper normality,AKP≥2.5 X Upper normality

Key Trial Info

Start Date :

April 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2018

Estimated Enrollment :

570 Patients enrolled

Trial Details

Trial ID

NCT00714077

Start Date

April 1 2008

End Date

June 1 2018

Last Update

February 17 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Jing Jin

Beijing, Beijing Municipality, China, 100021

2

Jing Jin

Beijing, Beijing Municipality, China, 100021

Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer | DecenTrialz